Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 16 April 2002
Vol. 2002, Issue 128, p. tw144
[DOI: 10.1126/stke.2002.128.tw144]

Immunology Going Against the Flow

The mechanism of action of a drug already used for immunosuppression reveals a new level of regulation of lymphocyte. Mandala et al. show that the active form of the drug FTY720 becomes phosphorylated once administered and resembles sphingosine-1-phosphate, a lipid whose activation of cognate receptors has been implicated in modulating the immune response. The drug and lipid achieve immunosuppressive effects by inhibiting the circulation of lymphocytes in the body.

S. Mandala, R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G.-J. Shei, D. Card, C. A. Keohane, M. Rosenbach, J. Hale, C. L. Lynch, K. Rupprecht, W. Parsons, H. Rosen, Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346-349 (2002). [Abstract] [Full Text]

Citation: Going Against the Flow. Sci. STKE 2002, tw144 (2002).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882